STOCKHOLM, SE / ACCESS Newswire / November 21, 2025 / iZafe Group (STO:IZAFE-B) - announces that the company has entered into a strategic partnership with Vakt og Alarm, one of Norway's most ...

Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff ...

Senior professionals in the life sciences must approach networking with strategic intention; not simply exchanging business ...

The best rhinoplasty in Seattle is by Dr. Sajan SEATTLE, WA / ACCESS Newswire / November 20, 2025 / In Seattle's growing ...

Together, the organizations will strengthen revenue cycle operations as Sauk Prairie Healthcare leverages Jorie AI's intelligent automation framework. PRAIRIE DU SAC, WISCONSIN / ACCESS Newswire / ...

Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire ...

First-of-its-kind AI-powered chronic care management platform moves clinically proven tools outside the doctor's office ARLINGTON, VA / ACCESS Newswire / November 20, 2025 / FriskaAi, an innovative ...

CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation. MESA, ARIZONA / ACCESS Newswire / November 20, ...

KENNESAW, GA / ACCESS Newswire / November 20, 2025 / When many people hear the term artificial intelligence, their guard goes up, questions are raised about confidentiality, integrity, and a ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine franchise from three to up to six approved products ...

With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative, patient-centered treatment for complex gynecologic ...

GOTHENBURG, SE / ACCESS Newswire / November 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that ...